Skip to content
Home/Companies/MedTech/Perfuze
Perfuze

Perfuze

MedTech·Ireland·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Perfuze?

Perfuze is currently owned by Earlybird Venture Capital through Earlybird Health (2017 vintage), since 2022.

Hand-verified · updated 2026-08-10

Earlybird Venture Capital
Investor
Earlybird Venture Capital
Earlybird Health · 2017 · VC

Key facts

HQIreland
SectorMedTech
StatusActive
Websitewww.perfuze.com

More from Earlybird Health

Other portfolio companies in the same fund.

Axon Vascular Europe
Active
MedTechUnited Kingdom· 2025
Haya Therapeutics
Haya Therapeutics
Active
BiotechSwitzerland· 2025
Hilo
Hilo
Active
MedTechSwitzerland· 2025
Portal Biotech
Active
BiotechUnited Kingdom· 2025
Rivia
Active
HealthTechSwitzerland· 2025
Gemma Biotherapeutics
Gemma Biotherapeutics
Active
BiotechUnited States· 2024

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Optos
Exited 2015
Amadeus Capital PartnersUK
to
Axomove
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Clee Medical
Clee Medical
Active
High-Tech Gruenderfonds (HTGF)Switzerland· 2026
CollimateHealth
Active
Caesar Ventures ManagementGermany· 2026
Track Perfuze

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Perfuze.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue